“Access to information literally saves lives”: free access to UpToDate in LMICs

This week, Yannis Valtis joined us for a short conversation about a new paper he and colleagues recently published in BMJ Global Health. Their study Read More


Malaria burden and costs of intensified control in Bhutan, 2006–14: an…

The malaria burden in Bhutan decreased significantly during the study period with high coverage of long-lasting insecticidal nets. The foreseeable challenges that require national attention to maintain a malaria-free status after elimination are importation of malaria, especially from India; continued protection of the population in endemic districts through complete coverage with long-lasting insecticidal nets and indoor residual spraying; and exploration of local funding modalities post-elimination in the event of a reduction in international funding.


Lifting the Patent Barrier to New Drugs and Energy Sources – The New York Times

Strict patents on technology have had the effect of hindering global progress in some fields, especially in combating disease and climate change. Source: Lifting the Read More


Experience Of, Lessons From Addressing NCDs In Wealthy Nations Must Be Applied To LMICs

Project Syndicate: Globalizing the Fight Against Non-Communicable Disease George Weisz, professor of the history of medicine at McGill University “Global health organizations and initiatives … have traditionally focused on infectious diseases, from malaria … to smallpox … But there has long been a tiny corner of global health that has targeted chronic non-communicable diseases (NCDs)…More

The return of chloroquine-susceptible Plasmodium falciparum malaria in Zambia

Plasmodium falciparum resistance to anti-malarial drugs remains a major obstacle to malaria control and elimination.

Emerging polymorphisms in falciparum Kelch 13 gene in Northeastern region of India

Recent reports of emergence and spread of artemisinin resistance in the Southeast Asia region, including Myanmar, pose a greater threat to malaria control and elimination in India.

CSIS Report Identifies Opportunities To Strengthen Global TB Response

Center for Global Health Policy’s “Science Speaks”: Raise profile, funding of global TB response to match advances seen in HIV, malaria efforts, report says Antigone Barton, senior editor and writer of “Science Speaks,” discusses findings from a report released by the Center for Strategic and International Studies (CSIS) on the U.S. government’s role in the…More

Perceptions on the effect of small electric fans on comfort inside bed nets in southern Ghana:…

Long-lasting insecticidal nets (LLINs) are known to be highly effective in reducing malaria transmission, morbidity and mortality.

Evaluation of long-lasting microbial larvicide for malaria vector control in Kenya

Outdoor malaria transmission is becoming an increasingly important problem in malaria control in Africa.

Susceptibility of Anopheles gambiae to insecticides used for malaria vector control in Rwanda

The widespread emergence of resistance to pyrethroids is a major threat to the gains made in malaria control.

In vitro and in vivo anti-malarial activity of novel harmine-analog heat shock protein 90…

The emergence of artemisinin-resistant Plasmodium falciparum strains poses a serious challenge to the control of malaria.

Environmental determinants of malaria transmission in African villages

Malaria transmission is complex, involving a range of hydroclimatological, biological, and environmental processes.

Nigeria Considering Innovative Financing Mechanism For Malaria Prevention

Financial Times: World Bank health care social impact bond fundraising targets Africa malaria “Malaria may not seem an obvious focus for financial markets but Nigeria plans an ambitious new instrument to tackle the heavy burden of the disease. If it goes ahead, the Innovative Financing for Malaria Prevention and Treatment/Control Project (Impact) will seek up…More

Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium…

Malawi experienced prolonged use of sulfadoxine/pyrimethamine (SP) as the front-line anti-malarial drug, with early replacement of chloroquine and delayed introduction of artemisinin-based combination therapy….

Plasmodium malariae in the Colombian Amazon region: you don’t diagnose what you don’t…

Malaria is a worldwide public health problem; parasites from the genus Plasmodium spp.

WHO welcomes global health funding for malaria vaccine

The world’s first malaria vaccine will be rolled out in pilot projects in sub-Saharan Africa, WHO confirmed today. Funding is now secured for the initial phase of the programme and vaccinations are due to begin in 2018. The vaccine, known as RTS,S, acts against P. falciparum, the most deadly malaria parasite globally, and the most prevalent in Africa. Advanced clinical trials have shown RTS,S to provide partial protection against malaria in young children.

News Outlets Look At Ethics, Effectiveness Of Various Malaria Prevention Methods

The Economist: Malaria: The biter bit “…Mosquitoes do not tend to fly far from the place they hatch, and experiments suggest that if most of a village’s inhabitants were to take ivermectin they could collectively do serious damage to the local Anopheles population. That would substantially reduce the number of cases of malaria in an…More

Older Posts »